文献速递临床生化质量管理与危急值

以HbA1c为模型测量项目设定分析性能规范

Setting analytical performance specifications using HbA1c as a model measurand.
PubMed 文献 · Clin Chim Acta · 2021-10-16

本综述讨论了分析性能规范(APS)的设定差异,以HbA1c为模型。基于结局的先验APS设定仍具挑战性;基于健康个体生物学变异的APS几乎所有常规方法无法达到;外部质量保证计划的APS逐步收紧并促进质量提升。实验室应选择适合其预期临床用途的APS并记录依据。

要点

  • 基于生物学变异的HbA1c APS几乎无法被常规方法达到
  • 外部质量保证计划的APS逐步收紧,促进检测质量提升
  • 实验室应选择适合临床用途的APS并记录数据与理由

核心结论

  • 以HbA1c为模型,APS设定存在广泛差异,基于结局的先验APS仍具挑战性。
  • 基于健康个体生物学变异的APS几乎无法被常规HbA1c方法达到。
  • 外部质量保证计划的APS逐步收紧,促进了HbA1c检测质量提升。
  • 实验室应选择适合预期临床用途的APS并记录依据,区域或国家宜采用共同APS。

研究设计与样本

  • 综述,以HbA1c为模型测量项目讨论分析性能规范的设定。

主要发现

  • 基于健康个体生物学变异估计的APS几乎无法被常规HbA1c检测方法达到。
  • 外部质量保证计划采用的APS已逐步收紧,促进了HbA1c检测质量提升。

临床怎么用

  • 实验室应选择适合其预期临床用途的APS并记录支持选择的数据和理由。
  • 在可能的情况下,区域或国家应采用共同APS以促进患者和患者数据跨机构流动。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Analytical performance specifications (APS) for measurands describe the minimum analytical quality requirements for their measurement. These APS are used to monitor and contain the systematic (trueness/bias) and random errors (precision/imprecision) of a laboratory measurement to ensure the results are "fit for purpose" in informing clinical decisions about managing a patient's health condition. In this review, we highlighted the wide variation in the setting of APS, using different levels of evidence, as recommended by the Milan Consensus, and approaches. The setting of a priori defined outcome-based APS for HbA1c remains challenging. Promising indirect alternatives seek to link the clinical utility of HbA1c and APS by defining statistical confidence for interpreting the laboratory values, or through simulation of clinical performance at varying levels of analytical performance. APS defined based on biological variation estimates in healthy individuals using the current formulae are unachievable by nearly all routine laboratory methods for HbA1c testing. On the other hand, the APS employed in external quality assurance programs have been progressively tightened, and greatly facilitate the improved quality of HbA1c testing. Laboratories should select the APS that fits their intended clinical use and should document the data and rationale underpinning those selections. Where possible common APS should be adopted across a region or country to facilitate the movement of patients and patient data across health care facilities.

来源:Clin Chim Acta,查看原文。版权归原作者所有。

引用

  1. Loh TP, Smith AF, Bell KJL, et al. Setting analytical performance specifications using HbA1c as a model measurand. Clin Chim Acta. 2021. PMID: 34666026. doi:10.1016/j.cca.2021.10.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。